| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Seed |
| Investing | Canada • Israel |
Hippocrates VC is a venture capital fund headquartered in the USA that specializes in Seed investments. With a strong commitment to transforming the healthcare industry, they focus on supporting innovative companies in the early stages of development.
The fund primarily invests in startups that bring technological advancements to healthcare, prioritizing those with demonstrable evidence-based digital therapeutic solutions. Notable portfolio companies include Smiley Scope, known for their virtual reality neuromodulation technology that aims to improve patient outcomes in various medical procedures, from burns dressings to medical imaging. Hippocrates VC also backs Avive AED, a company dedicated to increasing the survival rate of sudden cardiac arrest victims by developing reliable, engaging, and proactive life-saving tools.
Additionally, they support Fruit Street, which delivers the CDC’s diabetes prevention program through telehealth platforms, utilizing live group video conferencing with registered dietitians to aid in the prevention of diabetes. Their investment thesis underscores the potential of digital health solutions to enhance patient experiences and improve clinical outcomes.
By diligently meeting people at their level, Hippocrates VC builds a portfolio that reflects passion and effectiveness in technology that not only addresses current health challenges but also paves the way for a more resilient and accessible healthcare future.

